Apricus Biosciences expands commercial oncology offerings through agreement with PediatRx for U.S. co-promotion of …
SAN DIEGO, CA, and CALIFON, NJ, Jan. 27, 2012 /PRNewswire/ – Apricus Biosciences, Inc. (“Apricus Bio” or the “Company”) (Nasdaq: APRI http://www.apricusbio.com ) and PediatRx, Inc.
View original post here:
